AdaptHealth (AHCO) Expected to Announce Earnings on Tuesday

AdaptHealth (NASDAQ:AHCO) is anticipated to post its quarterly earnings results before the market opens on Tuesday, February 25th. Analysts expect AdaptHealth to post earnings of $0.25 per share and revenue of $829.19 million for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

AdaptHealth Stock Down 3.3 %

Shares of NASDAQ AHCO opened at $8.48 on Friday. AdaptHealth has a 52 week low of $7.16 and a 52 week high of $11.90. The business has a 50-day simple moving average of $9.85 and a two-hundred day simple moving average of $10.19. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. The company has a market cap of $1.14 billion, a P/E ratio of -5.14, a P/E/G ratio of 1.12 and a beta of 1.12.

Analyst Ratings Changes

Several research analysts have commented on the company. UBS Group cut their target price on AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Truist Financial lowered their price target on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, November 15th. Royal Bank of Canada lowered their price target on AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a report on Tuesday, November 19th. Robert W. Baird lowered their price target on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a report on Wednesday, November 6th. Finally, Canaccord Genuity Group lowered their price target on AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, November 6th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $12.20.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.